news
16 June 2016
Boston CEO and Bio Meetings, USA
Share
Genpharm management have successfully completed the US tour of 2016.
The Health Sciences CEO Boston gathering was followed by the annual Biotechnology Convention, the largest industry meeting.
This year’s key highlights and discussions included the pricing and political debate ranging across the pharmaceutical industry in particular for orphan drugs and the advances in scientific and clinical research, mainly the latest breakthroughs in CNS treatments.
Managing Partners at Genpharm, Mr Karim Smaira and Kamel Ghammachi during the panel discussion at the BIO convention 2016 with the President and CEO of Massachusetts Biotechnology Council, Mr. Robert Coughlin.